Esperion Therapeutics
ESPR
ESPR
122 hedge funds and large institutions have $75.9M invested in Esperion Therapeutics in 2023 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 22 closing their positions.
Holders
122
Holders Change
-2
Holders Change %
-1.61%
% of All Funds
1.95%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
21
Increased
36
Reduced
31
Closed
22
Calls
$1.67M
Puts
$335K
Net Calls
+$1.33M
Net Calls Change
+$231K
Top Buyers
1 |
TSC
1
Two Seas Capital
Rye,
New York
|
$7.52M |
2 |
2
Millennium Management
New York
|
$5.68M |
3 |
![]()
3
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$2.22M |
4 |
![]()
4
JPMorgan Chase & Co
New York
|
$1.83M |
5 |
![]()
5
Marshall Wace
London,
United Kingdom
|
$1.54M |